Hasil Pencarian - F. Linzee Mabrey
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 6 hasil dari 6
-
1
TLRs in COVID-19: How they drive immunopathology and the rationale for modulation oleh F. Linzee Mabrey, Eric D Morrell, Mark M Wurfel
Diterbitkan 2021-10-01Dapatkan teks lengkap
Artikel -
2
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach oleh Neha A. Sathe, Su Xian, F. Linzee Mabrey, David R. Crosslin, Sean D. Mooney, Eric D. Morrell, Kevin Lybarger, Meliha Yetisgen, Gail P. Jarvik, Pavan K. Bhatraju, Mark M. Wurfel
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
3
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness oleh F. Linzee Mabrey, MD, Leila R. Zelnick, PhD, Eric D. Morrell, MD, Nicholas G. O’Connor, BS, Andrew Hart, BA, Mark M. Wurfel, MD, PhD, W. Conrad Liles, MD, PhD, Pavan K. Bhatraju, MD, MSc
Diterbitkan 2022-09-01Dapatkan teks lengkap
Artikel -
4
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019 oleh F. Linzee Mabrey, MD, Eric D. Morrell, MD, Pavan K. Bhatraju, MD, MSc, Neha A. Sathe, MD, Sana S. Sakr, PhD, Sharon K. Sahi, BS, T. Eoin West, MD, MPH, Carmen Mikacenic, MD, Mark M. Wurfel, MD, PhD
Diterbitkan 2021-12-01Dapatkan teks lengkap
Artikel -
5
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumo... oleh F. Linzee Mabrey, Hui Nian, Chang Yu, Elizabeth M. Barnes, Uma Malhotra, Carmen Mikacenic, Julia Goldstein, D. Shane O'Mahony, Julia Garcia-Diaz, Patricia Finn, Kirk Voelker, Eric D. Morrell, Wesley H. Self, Patrice M. Becker, Thomas R. Martin, Mark M. Wurfel
Diterbitkan 2023-07-01Dapatkan teks lengkap
Artikel -
6
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19 oleh F. Linzee Mabrey, MD, Pavan K. Bhatraju, MD, MSc, Eric D. Morrell, MD, Leila R. Zelnick, PhD, Neha A. Sathe, MD, Nicholas G. O’Connor, BS, Carmen Mikacenic, MD, Thomas R. Martin, MD, W. Conrad Liles, MD, PhD, Mark M. Wurfel, MD, PhD
Diterbitkan 2022-12-01Dapatkan teks lengkap
Artikel